does bcbs cover glp-1 BCBSM pulling back on coverage BCBS VT nonsensical rationale for

Gastroenterologists are being increasingly consulted for the side effects, and a discussion around best management of these symptoms is presented

Tirzepatide, a dual GIP/GLP-1 receptor agonist, powers both Mounjaro (diabetes) and Zepbound (weight management)

Tirzepatide gained FDA approval for sleep apnoea

Risk factors for decreased bone mineral density in inflammatory bowel disease: a cross-sectional study

We think this is important people taking GLP-1s and doctors prescribing them should be on the lookout for these side effects

doi: 10.1210/jc.2014-4347 86 JrgensenAPUelandTSode-CarlsenRSchreinerTRabbenKFFarholtSet al